Literature DB >> 12404216

Primary chronic interstitial nephritis in Crohn's disease.

Hassane Izzedine1, Jeanne Simon, Anne-Marie Piette, Michel Lucsko, Alain Baumelou, Didier Charitanski, Eve Kernaonet, Anne-Catherine Baglin, Gilbert Deray, Hélène Beaufils.   

Abstract

BACKGROUND & AIMS: In Crohn's disease, cases of interstitial nephritis with renal failure have been reported in connection with the use of mesalamine.
METHODS: We observed 4 patients with severe interstitial nephritis proven by examination of kidney biopsy specimens. Renal failure was discovered before or simultaneously with the diagnosis of Crohn's disease, and patients were not treated with mesalamine. Impairment of renal function progressed to end-stage renal failure in 3 of the 4 patients.
RESULTS: Our results show that the kidney can be an extraintestinal target of Crohn's disease.
CONCLUSIONS: Several unanswered questions remain concerning the frequency of interstitial nephritis in patients with Crohn's disease, as well as the exact role of mesalamine in the development of chronic interstitial nephritis.

Entities:  

Mesh:

Year:  2002        PMID: 12404216     DOI: 10.1053/gast.2002.36613

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  21 in total

Review 1.  Extraintestinal complications of inflammatory bowel disease.

Authors:  Tim Orchard
Journal:  Curr Gastroenterol Rep       Date:  2003-12

2.  Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.

Authors:  R F Logan; T P van Staa
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 3.  Extraintestinal manifestations and complications in IBD.

Authors:  Claudia Ott; Jürgen Schölmerich
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-07-09       Impact factor: 46.802

4.  Role of tumor necrosis factor inhibitor in granulomatous interstitial nephritis secondary to Crohn's disease.

Authors:  Manish K Saha; Hamieh Tarek; Vishal Sagar; Paul Abraham
Journal:  Int Urol Nephrol       Date:  2012-12-30       Impact factor: 2.370

5.  Acute tubular injury associated with mesalazine therapy in an adolescent girl with inflammatory bowel disease.

Authors:  Nuray Uslu; Hulya Demir; Inci Nur Saltik-Temizel; Rezan Topaloğlu; Figen Gürakan; Aysel Yüce
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

6.  Acute kidney injury in a girl with ulcerative colitis and cytomegalovirus-induced focal segmental glomerular sclerosis.

Authors:  Sankar R Chirumamilla; Chun He; Lorraine C Racusen; Ann O Scheimann; Carmen Cuffari
Journal:  World J Pediatr       Date:  2011-08-27       Impact factor: 2.764

7.  Are renal microgranulomas related to inflammatory tubular destruction?

Authors:  A Mahmood; D N Poller; J K Ramage
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

8.  Interstitial nephritis from mesalazine: case report and literature review.

Authors:  Lois J Arend; James E Springate
Journal:  Pediatr Nephrol       Date:  2004-03-09       Impact factor: 3.714

9.  Inflammatory bowel disease and systemic AA amyloidosis.

Authors:  Prayman T Sattianayagam; Julian D Gillmore; Jennifer H Pinney; Simon D J Gibbs; Ashutosh D Wechalekar; Janet A Gilbertson; Dorota Rowczenio; Philip N Hawkins; Helen J Lachmann
Journal:  Dig Dis Sci       Date:  2013-01-31       Impact factor: 3.199

10.  Renal effects of long-term treatment with 5-aminosalicylic acid.

Authors:  H Patel; A Barr; K N Jeejeebhoy
Journal:  Can J Gastroenterol       Date:  2009-03       Impact factor: 3.522

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.